Kenya Research Station and Viral Infectious Disease Research

Why infectious disease research needs community ecology.

Infectious diseases often emerge from interactions among multiple species and across nested levels of biological organization. Threats as diverse as Ebola virus, human malaria, and bat white-nose syndrome illustrate the need for a mechanistic understanding of the ecological interactions underlying emerging infections. We describe how recent advances in community ecology can be adopted to addres...

Ethical and legal issues in infectious disease research and control.

Emerging Infectious Diseases Vol. 7, No. 3 Supplement, June 2001 534 lettuce, strawberries, and broccoli for Salmonella, Shigella, and Escherichia coli O157:H7. To date, 95.4% of these samples have been free of contamination. FDA has worked closely with several countries (e.g., Costa Rica, Trinidad and Tobago, Honduras, and Jamaica) to determine their needs and capacities. Examples of training ...

Epidemiologic and economic strategy in infectious disease research.

Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.

Financing for global health is a critical element of research and development. Innovations in new vaccines are critically dependent on research funding given the large sums required, however estimates of global research investments are lacking. We evaluate infectious disease research investments, focusing on immunology and vaccine research by UK research funding organisations. In 1997-2010, £2....

Biocontainment in Gain-of-Function Infectious Disease Research

The discussion of H5N1 influenza virus gain-of-function research has focused chiefly on its risk-to-benefit ratio. Another key component of risk is the level of containment employed. Work is more expensive and less efficient when pursued at biosafety level 4 (BSL-4) than at BSL-3 or at BSL-3 as modified for work with agricultural pathogens (BSL-3-Ag). However, here too a risk-to-benefit ratio a...